Terms: = Germ cell tumor AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Treatment
7 results:
1. Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.
Qu S; Qi S; Zhang H; Li Z; Wang K; Zhu T; Ye R; Zhang W; Huang G; Yi GZ
J Exp Clin Cancer Res; 2023 Oct; 42(1):285. PubMed ID: 37891669
[TBL] [Abstract] [Full Text] [Related]
2. Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.
Yi GZ; Huang G; Guo M; Zhang X; Wang H; Deng S; Li Y; Xiang W; Chen Z; Pan J; Li Z; Yu L; Lei B; Liu Y; Qi S
Brain; 2019 Aug; 142(8):2352-2366. PubMed ID: 31347685
[TBL] [Abstract] [Full Text] [Related]
3. Sequential decitabine and carboplatin treatment increases the DNA repair protein xpc, increases apoptosis and decreases proliferation in melanoma.
Budden T; van der Westhuizen A; Bowden NA
BMC Cancer; 2018 Jan; 18(1):100. PubMed ID: 29373959
[TBL] [Abstract] [Full Text] [Related]
4. Repair of UVB-induced DNA damage is reduced in melanoma due to low xpc and global genome repair.
Budden T; Davey RJ; Vilain RE; Ashton KA; Braye SG; Beveridge NJ; Bowden NA
Oncotarget; 2016 Sep; 7(38):60940-60953. PubMed ID: 27487145
[TBL] [Abstract] [Full Text] [Related]
5. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/xpc-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract] [Full Text] [Related]
6. xpc silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage.
Liu SY; Wen CY; Lee YJ; Lee TC
Toxicol Sci; 2010 Jul; 116(1):183-93. PubMed ID: 20403967
[TBL] [Abstract] [Full Text] [Related]
7. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
[TBL] [Abstract] [Full Text] [Related]
